MPLT MapLight Therapeutics, Inc.
$8.07▼ -1.22%
Healthcare
Other
Volume 186.7K
Avg Volume (10D) 373.8K
Key Metrics & Fundamentals
Market Cap
$448.50M
P/E Ratio
–
Div Yield
0.00%
52W Range
7.46 - 40.43
% vs 50 MA
-23.59%
% vs 200 MA
-60.49%
RSI-14
36.3
MACD Histogram
+0.1400
Beta (1Y vs SPY)
0.89
Free Cash Flow
-$44.89M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$63.40M
COGS
–
Operating Exp
$63.55M
Operating Income
-$63.55M
EBIT
-$63.55M
Pretax Income
-$60.19M
Net Income
-$60.19M
EPS (Diluted)
-1.32
Price & Volume History
Loading chart…
Recent News
Down 29.2% in 4 Weeks, Here's Why You Should You Buy the Dip in MapLight Therapeutics, Inc. (MPLT)
Zacks · Oct 16, 2026 8:35 AM ET
Down 34.8% in 4 Weeks, Here's Why MapLight Therapeutics, Inc. (MPLT) Looks Ripe for a Turnaround
Zacks · Oct 14, 2026 8:35 AM ET
MapLight Therapeutics Celebrates Co-Founder Dr. Karl Deisseroth on Receipt of 2026 Nobel Prize in Physiology or Medicine for the Development of Optogenetics
GlobeNewswire · Oct 6, 2026 7:00 AM ET
Guggenheim Initiates MapLight Therapeutics at Neutral
MT Newswires · Oct 6, 2026 6:00 AM ET
IPO Stock LB Pharma Has Tripled In Under A Year. Is It A Takeover Target?
Investor's Business Daily · Sep 9, 2026 8:00 AM ET
MapLight Therapeutics to Participate in Upcoming Investor Conference
GlobeNewswire · Sep 9, 2026 7:00 AM ET
AstraZeneca scores in lung cancer; Sandoz inks a China deal
BioPharma Dive · Aug 18, 2026 7:13 AM ET
MapLight Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
GlobeNewswire · Aug 13, 2026 4:05 PM ET
Sector Update: Healthcare Stocks Softer Late Afternoon
MT Newswires · Aug 13, 2026 3:36 PM ET
Sector Update: Healthcare Stocks Softer in Afternoon Trading
MT Newswires · Aug 13, 2026 1:50 PM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See MPLT's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.